Apogee Therapeutics, Inc.
Apogee Therapeutics, Inc. (APGE) is a publicly traded company in the Unknown sector. Across all available filings, 6 corporate insiders have executed 52 transactions totaling $227.1M, demonstrating a bearish sentiment with -$67.6M in net insider flow. The most recent transaction on Jan 22, 2026 involved a sale of 1,750,000 shares valued at $133.5M.
APGE Insider Activity Summary
Who Is Buying APGE Stock?
No significant insider buying has been recorded for APGE in the recent period.
Who Is Selling APGE Stock?
No significant insider selling has been recorded for APGE in the recent period.
Is Apogee Therapeutics, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for APGE is bearish with an Insider Alignment Score of 35/100 and a net flow of -$67.6M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
APGE Frequently Asked Questions
Understanding APGE Insider Activity
Insider trading at Apogee Therapeutics, Inc. (APGE) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 6 insiders are actively trading APGE stock, having executed 52 transactions in the past 90 days. The most active insider is Funds Management Llc Fairmount (Executive), who has made 4 transactions totaling $183.5M.
Related Tools
Track Apogee Therapeutics, Inc. Insider Activity
Get notified when executives and directors at APGE file new Form 4 transactions